Amphetamine
Amphetamine may decrease the sedative activities of Acrivastine.
Benzphetamine
Benzphetamine may decrease the sedative activities of Acrivastine.
Benzylpenicilloyl polylysine
Acrivastine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.
Advertisement
BETAHISTINE
The therapeutic efficacy of Betahistine can be decreased when used in combination with Acrivastine.
Dextroamphetamine
Dextroamphetamine may decrease the sedative activities of Acrivastine.
Diethylpropion
Diethylpropion may decrease the sedative activities of Acrivastine.
Advertisement
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Acrivastine.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Acrivastine.
Lisdexamfetamine
Lisdexamfetamine may decrease the sedative activities of Acrivastine.
Advertisement
Lisdexamfetamine Dimesylate
Lisdexamfetamine may decrease the sedative activities of Acrivastine.
Mephentermine
Mephentermine may decrease the sedative activities of Acrivastine.
Methamphetamine
Methamphetamine may decrease the sedative activities of Acrivastine.
p-Hydroxyamphetamine
Hydroxyamphetamine may decrease the sedative activities of Acrivastine.
Phentermine
Phentermine may decrease the sedative activities of Acrivastine.
PHENTERMINE RESIN
Phentermine may decrease the sedative activities of Acrivastine.
Pseudoephedrine
Pseudoephedrine may decrease the sedative activities of Acrivastine.